policy
Withdrawal of FDA approval for animal drug products
Loss of an animal drug product can have adverse effects on animal health, animal welfare and food safety.
policy
Veterinary foresight and expertise in antimicrobial discussions
Veterinarians are the professionals responsible for medical decisions, antimicrobial stewardship, and conscientious oversight of antimicrobial use in…
policy
Veterinary dentistry
Veterinary dentistry, oral medicine, and oral surgery are part of the practice of veterinary medicine and are regarded as such under state veterinary…
policy
Veterinary compounding
Compounding is the customized manipulation of a drug by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs…
policy
Vaccination principles
Vaccines have been proven highly efficacious and beneficial to the health of veterinary patients, as well as the general public. Decisions about…
policy
UNDER REVIEWUse of aquatic animal therapeutic agents
The AVMA recognizes the need for sufficient approved therapeutics to facilitate safe and effective prevention, diagnosis, treatment and control of…
policy
Unapproved new animal drugs marketed as devices
The AVMA encourages increased enforcement in regulating the marketing of products represented as devices but appearing to be unapproved new animal…
policy
Therapeutic medications in racehorses
Health care decisions for individual horses are the responsibility of the veterinarian, trainer, and owner and must have the best interests of the…
policy
Therapeutic medications in competition equids
The AVMA condemns the administration of non-therapeutic or unprescribed medications to competition equids. Health care decisions regarding individual…
policy
The veterinary profession's role in addressing the opioid epidemic
AVMA strongly recommends that veterinarians, legislators, state veterinary medical boards, and state pharmacy boards work together to create practical…
policy
Sale of human-label drug products to veterinarians
Because there are a limited number of drugs labeled for use in animals, veterinarians need to have access to human-labeled prescription drugs to…
policy
Safety testing
The AVMA supports research to discover and develop safe and efficacious drugs, vaccines, biologicals, and medical devices that benefit animals and…
policy
Restriction of veterinary biologics to veterinarians' use
The AVMA supports USDA efforts to restrict all veterinary biologics used in disease control programs, those with high incidence of reactions, and…
policy
Representation to the United States Pharmacopeial Convention (USP)
The AVMA encourages expansion of veterinary membership to the USP, such as representation of veterinary pharmacologists.
policy
Removal or reduction of teeth in nonhuman primates and carnivores
The AVMA opposes removal or reduction of healthy teeth in nonhuman primates and carnivores, except when required for medical treatment or approved…
policy
Notification to the veterinarian of violative residues in foods of animal origin
Veterinarians have an essential role in preventing such violations and ensuring the appropriate and judicious use of pharmaceuticals on food animal…
policy
Limited prohibition on extralabel drug use
Any regulatory prohibition of extralabel drug use in animals should be science-based and as limited in scope as possible, consistent with protecting…
policy
UNDER REVIEWJudicious therapeutic use of antimicrobials in aquatic animal medicine
Aquatic animal veterinarians should use all therapeutants, including antimicrobials, judiciously to restore aquatic animal health, ensure continued…
policy
UNDER REVIEWJudicious therapeutic use of antimicrobials
Judicious therapeutic use of antimicrobials is a core principle of the broader goal of antimicrobial stewardship.
policy
Joint AVMA-FVE-CVMA statement on responsible and judicious use of antimicrobials
The AVMA, Federation of Veterinarians of Europe, and Canadian Veterinary Medical Association have jointly adopted this policy on responsible and…
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process
To help ensure adequate availability of veterinary drugs, the AVMA supports increased funding of the FDA Center for Veterinary Medicine for the NADA…
policy
Foot and mouth disease
Foot-and-mouth disease (FMD) is a severe, highly contagious viral disease of worldwide concern. View AVMA's recommendations for FMD preparedness and…